Literature DB >> 8192447

Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.

K M Wasan1, M G Rosenblum, L Cheung, G Lopez-Berestein.   

Abstract

We examined the influence of high-density lipoproteins (HDLs) and low-density lipoproteins (LDLs) on the toxicity of amphotericin B (AmpB) to fungal and renal cells. Candida albicans was incubated for 18 h at 37 degrees C with AmpB and deoxycholate (Fungizone) or liposomal AmpB (L-AmpB) (0.1 to 2.0 micrograms of AmpB per ml) in the presence or absence of HDLs or LDLs (0.5 mg of protein per ml). The MICs of AmpB and L-AmpB, whether or not HDLs or LDLs were present, were similar. LLC PK1 renal cells, derived from primary cultures of pig proximal tubular cells, were incubated for 18 h at 37 degrees C in serum-free medium that contained AmpB and deoxycholate or L-AmpB at 20 micrograms of AmpB per ml, HDLs or LDLs at 0.5 mg of protein per ml, mixtures of AmpB with HDLs or LDLs, and mixtures of L-AmpB with HDLs or LDLs. HDL-associated AmpB was less toxic than AmB to LLC PK1 cells (53.0% +/- 2.5% versus 81.3% +/- 3.6% cytotoxicity; P = 0.01), while LDL-associated AmpB was as toxic as AmpB. L-AmpB, HDL-associated L-AmpB, and LDL-associated L-AmpB were less toxic to LLC PK1 cells than was AmpB (48.3% +/- 1.5%, 25.5% +/- 2.2%, and 52.2% +/- 2.5% versus 81.3% +/- 3.6% cytotoxicity; P = 0.02). To further understand why HDL-associated AmpB reduced renal cytotoxic effects, the LLC PK1 cells were examined for the presence of HDL and LDL receptors. LLC PK1 cells expressed high-affinity (K(d) = 0.0538 nanograms/ml; 96,000 sites per cell) and low-affinity (K(d) = 222.22 nanograms/ml; 77 sites per cell) LDL receptors but only a low-affinity HDL receptor (K(d) = 71.43 nanograms/ml; 2 sites per cell). HDL-associated AmpB and LDL-associated AmpB were less toxic than AmpB to trypsinized LLC PK1 cells (46.6% +/- 10.9% and 16.8% +/- 15.98% versus 74.7% +/- 7.7% cytotoxicity; P = 0.02). HDL-associated AmB and LDL-associated L-AmpB were also less toxic than AmpB to the cells (20.4% +/- 6.2% and 13.5% +/- 8.6% versus 74.7% cytotoxicity; P = 0.01). The antifungal activities of AmpB and L-AmpB were not altered in the presence of HDLs or LDLs. We conclude that the reduced nephrotoxicity associated with the use of L-AmpB is related to a decreased uptake of AmpB by renal cells when AmpB is associated with HDLs because of the low level of expression of HDL receptors in these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192447      PMCID: PMC284430          DOI: 10.1128/AAC.38.2.223

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Effects of serum lipoproteins on damage to erythrocytes and Candida albicans cells by polyene antibiotics.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

2.  Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.

Authors:  S Jullien; J Brajtburg; J Bolard
Journal:  Biochim Biophys Acta       Date:  1990-01-15

3.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.

Authors:  G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; E M Hersh; R Juliano
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  Rapid, quantitative microassay for the monokine respiration inhibitory factor.

Authors:  J Klostergaard; R G Kilbourn; W A Foster; G Lopez-Berestein
Journal:  J Immunol Methods       Date:  1987-07-16       Impact factor: 2.303

5.  Interaction of plasma proteins and lipoproteins with amphotericin B.

Authors:  J Brajtburg; S Elberg; J Bolard; G S Kobayashi; R A Levy; R E Ostlund; D Schlessinger; G Medoff
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

6.  Circular dichroism for the determination of amphotericin B binding to liposomes.

Authors:  S Jullien; A Vertut-Croquin; J Brajtburg; J Bolard
Journal:  Anal Biochem       Date:  1988-07       Impact factor: 3.365

7.  Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.

Authors:  K M Wasan; G A Brazeau; A Keyhani; A C Hayman; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  Unusual lipid structures selectively reduce the toxicity of amphotericin B.

Authors:  A S Janoff; L T Boni; M C Popescu; S R Minchey; P R Cullis; T D Madden; T Taraschi; S M Gruner; E Shyamsunder; M W Tate
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.

Authors:  H J Krause; R L Juliano
Journal:  Mol Pharmacol       Date:  1988-09       Impact factor: 4.436

10.  Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.

Authors:  R L Juliano; C W Grant; K R Barber; M A Kalp
Journal:  Mol Pharmacol       Date:  1987-01       Impact factor: 4.436

View more
  24 in total

1.  Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.

Authors:  Andreas H Groll; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Raul M Alfaro; Christine King; Stephen C Piscitelli; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 2.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

3.  Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.

Authors:  K M Wasan; M Ramaswamy; S M Cassidy; M Kazemi; F W Strobel; R L Thies
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.

Authors:  M Ramaswamy; K D Peteherych; A L Kennedy; K M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.

Authors:  T J Walsh; V Yeldandi; M McEvoy; C Gonzalez; S Chanock; A Freifeld; N I Seibel; P O Whitcomb; P Jarosinski; G Boswell; I Bekersky; A Alak; D Buell; J Barret; W Wilson
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children.

Authors:  Jodi M Lestner; Andreas H Groll; Ghaith Aljayyoussi; Nita L Seibel; Aziza Shad; Corina Gonzalez; Lauren V Wood; Paul F Jarosinski; Thomas J Walsh; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.

Authors:  K M Wasan; J S Conklin
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin:cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats.

Authors:  K M Wasan; V B Grossie
Journal:  Experientia       Date:  1995-03-15

9.  Nanodisks derived from amphotericin B lipid complex.

Authors:  Megan Tufteland; Gang Ren; Robert O Ryan
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

10.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.